Reduced CaSR was evident in endometrial cancer relative to the normal specimen and was associated with multiple clinicopathological characteristics, including histologic grade, myometrial invasion, lymph node metastasis and E-cadherin and VEGFR3 expression. This evidence concerns the gene FLT4 and endometrial cancer.